Pengfei Li to Neovascularization, Pathologic
This is a "connection" page, showing publications Pengfei Li has written about Neovascularization, Pathologic.
Connection Strength
0.032
-
Kallistatin suppresses cancer development by multi-factorial actions. Crit Rev Oncol Hematol. 2017 May; 113:71-78.
Score: 0.032